Research-grade peptides · Third-party tested
K
New We now accept credit & debit cards at checkout! Use code CARD20 for 20% off
RESEARCH USE ONLY: All products are for in-vitro laboratory research purposes only. Not for human or animal consumption. Not FDA-approved. By using this site, you confirm you are 21+ and agree to our Terms of Service and Compliance Policy.

Semax vs Selank: Nootropic Peptide Research Comparison

Published: 2026-03-19Updated: 2026-03-19Category: Comparisons

Semax and Selank are the two most studied nootropic peptides in preclinical and clinical literature. Both were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, but they derive from different parent molecules and act through distinct receptor pathways. This guide compares the published research on each.

Structural Overview

PropertySemaxSelank
Full NameACTH(4-10) analogue with Pro-Gly-Pro extensionTuftsin analogue with Pro-Gly-Pro extension
Amino Acids7 (Met-Glu-His-Phe-Pro-Gly-Pro)7 (Thr-Lys-Pro-Arg-Pro-Gly-Pro)
Parent MoleculeACTH (adrenocorticotropic hormone)Tuftsin (Thr-Lys-Pro-Arg)
CAS Number80714-61-0129954-34-3
Primary Research AreaNeurotrophic signaling / cognitive modelsAnxiolytic / immunomodulatory models
Regulatory Status (Russia)Approved pharmaceutical (nasal spray)Approved pharmaceutical (nasal spray)
FDA Status (US)Not approved — available as RUO reference materialNot approved — available as RUO reference material

Mechanism of Action (Published Research)

Semax

Semax has been studied primarily for its effects on neurotrophic factor expression. In preclinical models, it has been observed to upregulate BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) expression. The Pro-Gly-Pro C-terminal extension stabilizes the peptide against enzymatic degradation, extending its half-life compared to the native ACTH(4-10) fragment. Published research includes studies on cerebral ischemia models, cognitive function in animal models, and neurotransmitter signaling pathways including dopamine and serotonin systems.

Selank

Selank is derived from tuftsin, an endogenous immunomodulatory tetrapeptide. In preclinical research, Selank has been studied for its influence on GABA signaling, with observations suggesting modulation of GABA-A receptor subunit expression. Published studies have examined its effects on anxiety-like behavior in animal models, enkephalin metabolism, and IL-6 cytokine modulation. The anxiolytic research profile distinguishes it from Semax's primarily cognitive/neurotrophic profile.

Key Research Differences

Research FocusSemaxSelank
Neurotrophic factorsBDNF and NGF upregulation observed in multiple modelsSome BDNF data, but not the primary research focus
Anxiety/stress modelsSecondary research areaPrimary research area — GABA modulation observed
Immune functionLimited dataIL-6 modulation, tuftsin-derived immunomodulatory effects
Ischemia modelsExtensive — neuroprotective observations in stroke modelsLimited ischemia-specific data
Enkephalin systemNot a primary focusObserved inhibition of enkephalin-degrading enzymes

Published Study Highlights

Semax: Dolotov et al. (2006) demonstrated BDNF mRNA upregulation in rat hippocampus and cortex. Shadrina et al. (2010) reported gene expression changes in neurotrophic pathways. Multiple Russian clinical studies have been published on cerebrovascular applications, though these are primarily available in Russian-language journals.

Selank: Seredenin et al. (2008) reported anxiolytic effects comparable to benzodiazepines in animal models without sedation or dependence observations. Uchakina et al. (2008) published on immunomodulatory effects including cytokine modulation. Zozulya et al. (2001) studied effects on enkephalin metabolism.

Research context: Both peptides are approved pharmaceuticals in Russia but remain unapproved in the US. They are available as research chemical reference materials for in-vitro laboratory use. All published references here are from peer-reviewed preclinical or clinical studies.

Availability

Both Semax and Selank are available at Pepta Labs with ≥99% HPLC purity and third-party COA: Semax 25mg | Selank 10mg. See our purity testing guide for details on HPLC methodology.

All information is sourced from published peer-reviewed literature and provided for educational purposes only. This content does not represent claims about products sold by Pepta Labs. All products are chemical reference materials for in-vitro laboratory research only. Not for human or animal consumption. See Terms of Service and Compliance Policy.

Browse Research Compounds

34+ peptides. Third-party COAs. Free US shipping.

View Catalog →